Work

Supplementary Figures 1-3 from Targeting the Spleen Tyrosine Kinase with Fostamatinib as a Strategy against Waldenström Macroglobulinemia

Year: 2023

Type: supplementary-materials

Abstract: Supplementary Figures 1-3. Supplementary Figure 1. Fostamatinib induces apoptosis in a dose-dependent manner. Supplementary Figure 2. Fostamatinib shows enhanced activity in combination with bendamustine. Supplementary Figure 3. Fostamatinib shows enhanced activity in combination with bendamustine.

Authors: Isere Kuiatse, Veerabhadran Baladandayuthapani, Heather Y. Lin, Sheeba K. Thomas, Chad C. Bjorklund, Donna M. Weber, Michael Wang, Jatin J. Shah, Xing-Ding Zhang, Richard J. Jones, Stephen M. Ansell, Guang Yang, Steven P. Treon, Robert Z. Orlowski

Language: English

Topic: Chronic Lymphocytic Leukemia Research

Subfield: Genetics

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: gold

OpenAlex ID: W4361884967

Cites:

Cited by:

Related to: 10